Padrón R S, Más J, de Acosta O M
Int J Androl. 1984 Dec;7(6):495-502. doi: 10.1111/j.1365-2605.1984.tb00806.x.
The change in plasma levels of testosterone and oestradiol-17-beta following a single intramuscular injection of 6000 IU hCG was studied in 7 men with non-tumoural hyperprolactinaemia and who were without clinical and/or laboratory evidence of hypogonadotrophism. These values were compared to the response of normal males to hCG. Plasma samples were obtained at 0, 2, 4, 24, 48, 96, 144, 192 and 240 h after hCG injection. The early and late phases of the plasma testosterone to hCG in hyperprolactinaemic patients were comparable to those of the controls, although the maximum and relative increment was somewhat diminished (5.0 +/- 1.2 vs 7.2 +/- 2.1 ng/ml; P less than 0.05, and 1.8 +/- 0.2 vs 2.3 +/- 0.5 ng/ml; P less than 0.02, respectively). The plasma oestradiol response to hCG was not different between the two groups, but the maximum and relative incement was higher in the hyperprolactinaemic patients (135.9 +/- 20.6 vs 97.1 +/- 11.9 pg/ml; P less than 0.05, and 4.9 +/- 0.6 vs 3.1 +/- 0.5 pg/ml; P less than 0.01, respectively. These findings suggest that the testosterone response to exogenous gonadotrophin is impaired in patients with non-tumoural hyperprolactinaemia. Whether this impairment is related to the higher increment in plasma levels of oestradiol remains to be elucidated. The data presented favour the hypothesis that in hyperprolactinaemic men, the prolactin exerts a direct action at the testicular level.
对7名非肿瘤性高泌乳素血症且无性腺功能减退临床和/或实验室证据的男性,研究了单次肌内注射6000 IU人绒毛膜促性腺激素(hCG)后睾酮和雌二醇-17-β血浆水平的变化。将这些值与正常男性对hCG的反应进行比较。在hCG注射后0、2、4、24、48、96、144、192和240小时采集血浆样本。高泌乳素血症患者血浆睾酮对hCG的早期和晚期阶段与对照组相当,尽管最大值和相对增量有所减少(分别为5.0±1.2 vs 7.2±2.1 ng/ml;P<0.05,以及1.8±0.2 vs 2.3±0.5 ng/ml;P<0.02)。两组间血浆雌二醇对hCG的反应无差异,但高泌乳素血症患者的最大值和相对增量更高(分别为135.9±20.6 vs 97.1±11.9 pg/ml;P<0.05,以及4.9±0.6 vs 3.1±0.5 pg/ml;P<0.01)。这些发现表明,非肿瘤性高泌乳素血症患者对外源性促性腺激素的睾酮反应受损。这种损害是否与血浆雌二醇水平的较高增量有关仍有待阐明。所呈现的数据支持这样的假设,即在高泌乳素血症男性中,泌乳素在睾丸水平发挥直接作用。